SecBot SecBot
8-K ·Filed Oct 26, 2026

SUPN

SUPERNUS PHARMACEUTICALS, INC.
NEUTRAL
Impact 2/10
Processed12h 34m ago SEC0001356576-26-000045
8-K material event: Items 1.02

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001356576-26-000045
Document: 0001356576-26-000045-index-headers.html0001356576-26-000045
Document: 0001356576-26-000045-index.html0001356576-26-000045
Document: 0001356576-26-000045.txt0001356576-26-000045
26 reports for SUPN
Performance horizon
67% Hit rate @ T+5 6 of 9 directional calls Went positive at some point 7 of 10 best @ T+60▲ +16.06%Jul 20, 2026
Filters
Rows
Reports for SUPN — sortable, filterable
TypeNow
Oct 26, 2026
today
8-K
NEUTRAL ★ 2/10
$40.77awaiting T+5—$40.77 (+0.00%)
Oct 21, 2026
5d ago
8-K
BULLISH ★ 6/10
$42.07awaiting T+5—$40.77 (−3.09%)
Oct 19, 2026
7d ago
8-K
NEUTRAL ★ 2/10
$41.23awaiting T+5—$40.77 (−1.12%)
Oct 19, 2026
7d ago
Press Release
NEUTRAL ★ 1/10
$39.84 $40.63▲ +1.98%▲ +2.13%$40.77 (+2.33%)
Oct 6, 2026
20d ago
425
NEUTRAL ★ 4/10
$42.83 $42.01▼ −1.91%▼ −1.78%$40.77 (−4.81%)
Oct 6, 2026
20d ago
DEFA14A
NEUTRAL ★ 3/10
$42.83 $42.01▼ −1.91%▼ −1.78%$40.77 (−4.81%)
Sep 11, 2026
6w ago
DEFM14A
MIXED ★ 7/10
$41.49 $42.78▲ +3.11%▲ +3.00%$40.77 (−1.74%)
Aug 3, 2026
12w ago
DEFA14A / 425
BULLISH ★ 7/10
$43.25 $46.88▲ +8.39%▲ +8.49%$40.77 (−5.73%)
Aug 3, 2026
12w ago
8-K
BULLISH ★ 7/10
$43.25 $46.88▲ +8.39%▲ +8.49%$40.77 (−5.73%)
Aug 3, 2026
12w ago
DEFA14A / 425
BULLISH ★ 8/10
$46.00 $47.07▲ +2.33%▲ +0.30%$40.77 (−11.37%)
Showing 10 of 26

US Market Status

Market Closed — Opens in 4h 13m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 26, 2026

Fresh SUPN Intelligence

Analysis is for subscribers only.

Subscribe for Full Access